Argenx Acquires Forte Biosciences in $2.2 Billion Deal

Argenx has agreed to acquire Forte Biosciences for $2.2 billion, a move aimed at strengthening its pipeline of autoimmune drugs with the addition of FB102.

Post Share

Sources

Showing 0 of 2 sources

No articles available in your preferred languages.

2 articles available in other languages below.

YahooDanish39d ago

argenx Strikes $2.2B Deal for Forte, Adds Autoimmune Drug FB102

Read full article →

seeking-alphanob39d ago

argenx strikes $2.2B deal for Forte Biosciences

Read full article →

Coverage Timeline

First report: seeking-alpha · 27 Jul, 08:20|Full coverage: 2 · 6h|Window: 6h

Left-leaningCenterRight-leaning

seeking-alpha27 Jul, 08:20First to report

argenx strikes $2.2B deal for Forte Biosciences

6h later

Yahoo27 Jul, 14:01Latest update

Argenx Acquires Forte Biosciences in $2.2 Billion Deal

Sources

argenx Strikes $2.2B Deal for Forte, Adds Autoimmune Drug FB102

argenx strikes $2.2B deal for Forte Biosciences

Coverage Timeline

argenx strikes $2.2B deal for Forte Biosciences

argenx Strikes $2.2B Deal for Forte, Adds Autoimmune Drug FB102

Related Stories

Volkswagen Announces Major Restructuring Plan Targeting 100,000 Jobs

Chinese Firms Halt Some Rare Earth Shipments to the United States

Strong U.S. Jobs Data Fuels Rate Hike Bets as Trump Threatens Trade Tariffs

Norway’s Sovereign Wealth Fund Plans Major Reduction in U.S. Treasury Holdings